vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and iQSTEL Inc (IQST). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $73.1M, roughly 1.2× Evolus, Inc.). iQSTEL Inc runs the higher net margin — -3.2% vs -14.6%, a 11.4% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (6.7% vs -14.9%). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs 4.6%).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
EOLS vs IQST — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $73.1M | $84.2M |
| Net Profit | $-10.7M | $-2.7M |
| Gross Margin | 66.9% | 3.5% |
| Operating Margin | 23.8% | -2.9% |
| Net Margin | -14.6% | -3.2% |
| Revenue YoY | 6.7% | -14.9% |
| Net Profit YoY | — | -44.5% |
| EPS (diluted) | $-0.16 | $-0.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $73.1M | — | ||
| Q4 25 | $90.3M | $84.2M | ||
| Q3 25 | $69.0M | $102.9M | ||
| Q2 25 | $69.4M | $72.2M | ||
| Q1 25 | $68.5M | $57.6M | ||
| Q4 24 | $78.9M | $98.9M | ||
| Q3 24 | $61.1M | $54.2M | ||
| Q2 24 | $66.9M | $78.6M |
| Q1 26 | $-10.7M | — | ||
| Q4 25 | $130.0K | $-2.7M | ||
| Q3 25 | $-15.7M | $-2.3M | ||
| Q2 25 | $-17.1M | $-2.3M | ||
| Q1 25 | $-18.9M | $-1.1M | ||
| Q4 24 | $-6.8M | $-1.9M | ||
| Q3 24 | $-19.2M | $-773.0K | ||
| Q2 24 | $-11.3M | $-2.0M |
| Q1 26 | 66.9% | — | ||
| Q4 25 | 65.7% | 3.5% | ||
| Q3 25 | 66.5% | 2.7% | ||
| Q2 25 | 65.3% | 2.6% | ||
| Q1 25 | 68.1% | 3.4% | ||
| Q4 24 | 66.7% | 2.7% | ||
| Q3 24 | 68.9% | 3.7% | ||
| Q2 24 | 70.3% | 2.8% |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 4.7% | -2.9% | ||
| Q3 25 | -16.7% | -0.5% | ||
| Q2 25 | -14.7% | -0.9% | ||
| Q1 25 | -22.1% | -1.0% | ||
| Q4 24 | -2.9% | -0.3% | ||
| Q3 24 | -25.3% | -0.1% | ||
| Q2 24 | -11.5% | -0.4% |
| Q1 26 | -14.6% | — | ||
| Q4 25 | 0.1% | -3.2% | ||
| Q3 25 | -22.8% | -2.3% | ||
| Q2 25 | -24.7% | -3.3% | ||
| Q1 25 | -27.6% | -2.0% | ||
| Q4 24 | -8.6% | -1.9% | ||
| Q3 24 | -31.4% | -1.4% | ||
| Q2 24 | -17.0% | -2.5% |
| Q1 26 | $-0.16 | — | ||
| Q4 25 | $0.01 | $-0.92 | ||
| Q3 25 | $-0.24 | $-0.68 | ||
| Q2 25 | $-0.27 | $-0.82 | ||
| Q1 25 | $-0.30 | $-0.44 | ||
| Q4 24 | $-0.11 | $-1.19 | ||
| Q3 24 | $-0.30 | $-0.40 | ||
| Q2 24 | $-0.18 | $-0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.8M | $2.2M |
| Total DebtLower is stronger | $156.4M | $4.1M |
| Stockholders' EquityBook value | — | $16.3M |
| Total Assets | $220.6M | $51.1M |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $49.8M | — | ||
| Q4 25 | $53.8M | $2.2M | ||
| Q3 25 | $43.5M | $2.3M | ||
| Q2 25 | $61.7M | $2.0M | ||
| Q1 25 | $67.9M | $1.1M | ||
| Q4 24 | $87.0M | $2.5M | ||
| Q3 24 | $85.0M | $2.1M | ||
| Q2 24 | $93.7M | $797.2K |
| Q1 26 | $156.4M | — | ||
| Q4 25 | $146.1M | $4.1M | ||
| Q3 25 | — | $2.7M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | $121.8M | $3.5M | ||
| Q4 24 | $121.5M | $2.5M | ||
| Q3 24 | $121.2M | $3.2M | ||
| Q2 24 | $120.9M | $2.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-23.1M | $16.3M | ||
| Q3 25 | $-28.8M | $17.9M | ||
| Q2 25 | $-18.7M | $14.3M | ||
| Q1 25 | $-6.6M | $11.6M | ||
| Q4 24 | $5.5M | $11.9M | ||
| Q3 24 | $5.9M | $8.1M | ||
| Q2 24 | $19.3M | $7.6M |
| Q1 26 | $220.6M | — | ||
| Q4 25 | $225.9M | $51.1M | ||
| Q3 25 | $219.0M | $46.9M | ||
| Q2 25 | $228.8M | $51.4M | ||
| Q1 25 | $213.4M | $42.0M | ||
| Q4 24 | $232.6M | $79.0M | ||
| Q3 24 | $229.6M | $32.4M | ||
| Q2 24 | $233.8M | $30.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.31× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | 22.00× | 0.21× | ||
| Q3 24 | 20.58× | 0.40× | ||
| Q2 24 | 6.26× | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.2M |
| Free Cash FlowOCF − Capex | — | $-1.2M |
| FCF MarginFCF / Revenue | — | -1.5% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $12.8M | $-1.2M | ||
| Q3 25 | $-14.7M | $-953.0K | ||
| Q2 25 | $-24.8M | $257.7K | ||
| Q1 25 | $-15.6M | $-1.9M | ||
| Q4 24 | $4.8M | $-403.7K | ||
| Q3 24 | $-5.7M | $625.0K | ||
| Q2 24 | $-6.5M | $-2.6M |
| Q1 26 | — | — | ||
| Q4 25 | $11.3M | $-1.2M | ||
| Q3 25 | $-15.6M | $-969.2K | ||
| Q2 25 | $-25.5M | $211.7K | ||
| Q1 25 | $-16.0M | $-2.0M | ||
| Q4 24 | $4.4M | $-421.3K | ||
| Q3 24 | $-6.0M | $594.5K | ||
| Q2 24 | $-6.9M | $-2.6M |
| Q1 26 | — | — | ||
| Q4 25 | 12.6% | -1.5% | ||
| Q3 25 | -22.7% | -0.9% | ||
| Q2 25 | -36.7% | 0.3% | ||
| Q1 25 | -23.3% | -3.4% | ||
| Q4 24 | 5.5% | -0.4% | ||
| Q3 24 | -9.9% | 1.1% | ||
| Q2 24 | -10.4% | -3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 1.0% | 0.1% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 0.5% | 0.1% | ||
| Q2 24 | 0.7% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 98.67× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
